Curcumin/Carrier Coprecipitation by Supercritical Antisolvent Route
In this work, polyvinylpyrrolidone (PVP)- and β-cyclodextrin (β-CD)-based composite powders containing curcumin (CURC) were obtained through the supercritical antisolvent (SAS) technique. Pressure, total concentration of CURC/carrier in dimethylsulfoxide, and CURC/carrier ratio effects on the morpho...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_4a0673b4d4374683b9fe97215462da02 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Stefania Mottola |e author |
700 | 1 | 0 | |a Iolanda De Marco |e author |
245 | 0 | 0 | |a Curcumin/Carrier Coprecipitation by Supercritical Antisolvent Route |
260 | |b MDPI AG, |c 2024-03-01T00:00:00Z. | ||
500 | |a 10.3390/pharmaceutics16030352 | ||
500 | |a 1999-4923 | ||
520 | |a In this work, polyvinylpyrrolidone (PVP)- and β-cyclodextrin (β-CD)-based composite powders containing curcumin (CURC) were obtained through the supercritical antisolvent (SAS) technique. Pressure, total concentration of CURC/carrier in dimethylsulfoxide, and CURC/carrier ratio effects on the morphology and size of the precipitated powders were investigated. Using PVP as the carrier, spherical particles with a mean diameter of 1.72 μm were obtained at 12.0 MPa, 20 mg/mL, and a CURC/PVP molar ratio equal to 1/2 mol/mol; using β-CD as the carrier, the optimal operating conditions were 9.0 MPa and 200 mg/mL; well-defined micrometric particles with mean diameters equal to 2.98 and 3.69 μm were obtained at molar ratios of 1/2 and 1/1 mol/mol, respectively. FT-IR spectra of CURC/ β-CD inclusion complexes and coprecipitated CURC/PVP powders revealed the presence of some peaks of the active compounds. The stoichiometry of the complexes evaluated through the Job method revealed that β-CD formed inclusion complexes with CURC at a molar ratio equal to 1/1. Dissolution profiles revealed that in comparison with the curve of the pure ingredient, the SAS-processed powders obtained using both PVP and β-CD have an improved release rate. | ||
546 | |a EN | ||
690 | |a inclusion complexes | ||
690 | |a coprecipitated microparticles | ||
690 | |a β-cyclodextrin | ||
690 | |a SAS precipitation | ||
690 | |a fast release | ||
690 | |a supercritical CO<sub>2</sub> | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pharmaceutics, Vol 16, Iss 3, p 352 (2024) | |
787 | 0 | |n https://www.mdpi.com/1999-4923/16/3/352 | |
787 | 0 | |n https://doaj.org/toc/1999-4923 | |
856 | 4 | 1 | |u https://doaj.org/article/4a0673b4d4374683b9fe97215462da02 |z Connect to this object online. |